We are live on
!
Find out more
CM
Capital Management Portfolio holdings
AUM
$585M
1-Year Est. Return
5.18%
This Fund
S&P 500
This Quarter
Est. Return
+14.1%
1 Year Est. Return
+5.18%
3 Year Est. Return
+40.88%
5 Year Est. Return
+39.5%
10 Year Est. Return
+202.53%
AUM
$364M
AUM Growth
+$41.7M
(+13%)
Cap. Flow
+$9.04M
Cap. Flow
% of AUM
2.48%
Top 10 Holdings %
Top 10 Hldgs %
36.8%
Holding
90
New
15
Increased
23
Reduced
33
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$10.2M |
| 2 |
SVC
Service Properties Trust
SVC
|
+$6.64M |
| 3 |
Pitney Bowes
PBI
|
+$6.48M |
| 4 |
Goldman Sachs
GS
|
+$4.67M |
| 5 |
LTHM
Livent Corporation
LTHM
|
+$4.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$10.5M |
| 2 |
Federated Hermes
FHI
|
+$9.24M |
| 3 |
Agnico Eagle Mines
AEM
|
+$8.29M |
| 4 |
Aflac
AFL
|
+$5.02M |
| 5 |
Supernus Pharmaceuticals
SUPN
|
+$3.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.44% |
| 2 | Industrials | 13.12% |
| 3 | Communication Services | 12.98% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Healthcare | 11.11% |
Similar funds
RIS
TAM
CGIM
HA
GIM
KI
PFG
AIM
Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Capital Management held 90 positions worth $364M, up 13% from $322M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Capital Management's Q1 2019 filing shows 15 new, 23 increased, 33 reduced and 8 closed positions. Its largest new stake was Celgene Corp: 116,120 shares worth $11M. The largest sale was Bristol-Myers Squibb, an estimated $10.5M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 23% a quarter earlier, followed by Industrials and Communication Services.
- Capital Management's largest Q1 2019 buy was Celgene Corp: 116,120 shares worth $11M.
- Capital Management added most to Service Properties Trust in Q1 2019, an estimated $6.64M increase.
- Capital Management's biggest Q1 2019 reduction was Aflac, cutting an estimated $5.02M.
- Capital Management fully exited Bristol-Myers Squibb in Q1 2019, selling an estimated $10.5M.
- Capital Management's ten largest holdings make up 37% of its $364M portfolio in Q1 2019.
- Capital Management opened 15 new positions and closed 8 in Q1 2019.
- Capital Management's portfolio value rose 13% quarter-over-quarter to $364M.
Based on Capital Management's 13F filing for Q1 2019, filed 25 Apr 2019.